A detailed history of River Park Advisors, LLC transactions in Rx Sight, Inc. stock. As of the latest transaction made, River Park Advisors, LLC holds 4,800 shares of RXST stock, worth $145,872. This represents 0.2% of its overall portfolio holdings.

Number of Shares
4,800
Previous 3,379 42.05%
Holding current value
$145,872
Previous $203,000 16.75%
% of portfolio
0.2%
Previous 0.17%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$40.78 - $57.04 $57,948 - $81,053
1,421 Added 42.05%
4,800 $237,000
Q2 2024

Jul 26, 2024

BUY
$50.42 - $64.29 $14,974 - $19,094
297 Added 9.64%
3,379 $203,000
Q1 2024

May 03, 2024

BUY
$35.51 - $57.92 $85,721 - $139,818
2,414 Added 361.38%
3,082 $158,000
Q4 2023

Jan 11, 2024

BUY
$20.91 - $40.9 $5,750 - $11,247
275 Added 69.97%
668 $26,000
Q3 2023

Nov 08, 2023

BUY
$27.05 - $33.37 $10,630 - $13,114
393 New
393 $10,000

Others Institutions Holding RXST

About RxSight, Inc.


  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $840M
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track This Portfolio

Track River Park Advisors, LLC Portfolio

Follow River Park Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of River Park Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on River Park Advisors, LLC with notifications on news.